|
1
|
Wang M and Casey PJ: Protein prenylation:
Unique fats make their mark on biology. Nat Rev Mol Cell Biol.
17:110–122. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boyartchuk VL, Ashby MN and Rine J:
Modulation of Ras and a-factor function by carboxyl-terminal
proteolysis. Science. 275:1796–1800. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Freije JM, Blay P, Pendás AM, Cadiñanos J,
Crespo P and López-Otín C: Identification and chromosomal location
of two human genes encoding enzymes potentially involved in
proteolytic maturation of farnesylated proteins. Genomics.
58:270–280. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gutierrez L, Magee AI, Marshall CJ and
Hancock JF: Post-translational processing of p21ras is two-step and
involves carboxyl-methylation and carboxy-terminal proteolysis.
EMBO J. 8:1093–1098. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
James G, Goldstein JL and Brown MS:
Resistance of K-RasBV12 proteins to farnesyltransferase inhibitors
in Rat1 cells. Proc Natl Acad Sci USA. 93:4454–4458. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Whyte DB, Kirschmeier P, Hockenberry TN,
Nunez-Oliva I, James L, Catino JJ, Bishop WR and Pai JK: K- and
N-Ras are geranylgeranylated in cells treated with farnesyl protein
transferase inhibitors. J Biol Chem. 272:14459–14464. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bergo MO, Ambroziak P, Gregory C, George
A, Otto JC, Kim E, Nagase H, Casey PJ, Balmain A and Young SG:
Absence of the CAAX endoprotease Rce1: Effects on cell growth and
transformation. Mol Cell Biol. 22:171–181. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bergo MO, Leung GK, Ambroziak P, Otto JC,
Casey PJ, Gomes AQ, Seabra MC and Young SG: Isoprenylcysteine
carboxyl methyltransferase deficiency in mice. J Biol Chem.
276:5841–5845. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kamiya Y, Sakurai A, Tamura S and
Takahashi N: Structure of rhodotorucine A, a novel lipopeptide,
inducing mating tube formation in Rhodosporidium toruloides.
Biochem Biophys Res Commun. 83:1077–1083. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Casey PJ, Solski PA, Der CJ and Buss JE:
p21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci
USA. 86:8323–8327. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Clarke S, Vogel JP, Deschenes RJ and Stock
J: Posttranslational modification of the Ha-ras oncogene protein:
Evidence for a third class of protein carboxyl methyltransferases.
Proc Natl Acad Sci USA. 85:4643–4647. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reiss Y, Goldstein JL, Seabra MC, Casey PJ
and Brown MS: Inhibition of purified p21ras farnesyl: Protein
transferase by Cys-AAX tetrapeptides. Cell. 62:81–88. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Seabra MC, Reiss Y, Casey PJ, Brown MS and
Goldstein JL: Protein farnesyltransferase and
geranylgeranyltransferase share a common alpha subunit. Cell.
65:429–434. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Otto JC, Kim E, Young SG and Casey PJ:
Cloning and characterization of a mammalian prenyl protein-specific
protease. J Biol Chem. 274:8379–8382. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dai Q, Choy E, Chiu V, Romano J, Slivka
SR, Steitz SA, Michaelis S and Philips MR: Mammalian prenylcysteine
carboxyl methyltransferase is in the endoplasmic reticulum. J Biol
Chem. 273:15030–15034. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bergo MO, Gavino BJ, Hong C, Beigneux AP,
McMahon M, Casey PJ and Young SG: Inactivation of Icmt inhibits
transformation by oncogenic K-Ras and B-Raf. J Clin Invest.
113:539–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang M, Hossain MS, Tan W, Coolman B, Zhou
J, Liu S and Casey PJ: Inhibition of isoprenylcysteine
carboxylmethyltransferase induces autophagic-dependent apoptosis
and impairs tumor growth. Oncogene. 29:4959–4970. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Teh JT, Zhu WL, Ilkayeva OR, Li Y, Gooding
J, Casey PJ, Summers SA, Newgard CB and Wang M: Isoprenylcysteine
carboxylmethyltransferase regulates mitochondrial respiration and
cancer cell metabolism. Oncogene. 34:3296–3304. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang J, Casey PJ and Wang M: Suppression
of isoprenylcysteine carboxylmethyltransferase compromises DNA
damage repair. Life Sci Alliance. 4:e2021011442021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Borini Etichetti C, Arel Zalazar E, Di
Benedetto C, Cocordano N, Valente S, Bicciato S, Menacho-Márquez M,
Larocca MC and Girardini J: Isoprenylcysteine carboxyl
methyltransferase (ICMT) promotes invadopodia formation and
metastasis in cancer cells. Biochimie. 222:28–36. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bergo MO, Leung GK, Ambroziak P, Otto JC,
Casey PJ and Young SG: Targeted inactivation of the
isoprenylcysteine carboxyl methyltransferase gene causes
mislocalization of K-Ras in mammalian cells. J Biol Chem.
275:17605–17610. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Diver MM, Pedi L, Koide A, Koide S and
Long SB: Atomic structure of the eukaryotic intramembrane RAS
methyltransferase ICMT. Nature. 553:526–529. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Diver MM and Long SB: Mutational analysis
of the integral membrane methyltransferase isoprenylcysteine
carboxyl methyltransferase (ICMT) reveals potential substrate
binding sites. J Biol Chem. 289:26007–26020. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang FL and Casey PJ: Protein
prenylation: Molecular mechanisms and functional consequences. Annu
Rev Biochem. 65:241–269. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cox AD, Der CJ and Philips MR: Targeting
RAS membrane association: Back to the future for Anti-RAS drug
discovery? Clin Cancer Res. 21:1819–1827. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
deSolms SJ, Ciccarone TM, MacTough SC,
Shaw AW, Buser CA, Ellis-Hutchings M, Fernandes C, Hamilton KA,
Huber HE, Kohl NE, et al: Dual protein
farnesyltransferase-geranylgeranyltransferase-I inhibitors as
potential cancer chemotherapeutic agents. J Med Chem. 46:2973–2984.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma C, Yang Y, Xu L, Tu W, Chen F and Wang
J: Rce1 suppresses invasion and metastasis of hepatocellular
carcinoma via epithelial-mesenchymal transition induced by the
TGF-β1/H-Ras signaling pathway. J Cell Physiol. 235:2506–2520.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aiyagari AL, Taylor BR, Aurora V, Young SG
and Shannon KM: Hematologic effects of inactivating the Ras
processing enzyme Rce1. Blood. 101:2250–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Karlsson C, Akula MK, Staffas A, Cisowski
J, Sayin VI, Ibrahim MX, Lindahl P and Bergo MO: Knockout of the
RAS endoprotease RCE1 accelerates myeloid leukemia by
downregulating GADD45b. Leukemia. 35:606–609. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Winter-Vann AM, Baron RA, Wong W, dela
Cruz J, York JD, Gooden DM, Bergo MO, Young SG, Toone EJ and Casey
PJ: A small-molecule inhibitor of isoprenylcysteine carboxyl
methyltransferase with antitumor activity in cancer cells. Proc
Natl Acad Sci USA. 102:4336–4341. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wright LP and Philips MR: Thematic review
series: Lipid posttranslational modifications. CAAX modification
and membrane targeting of Ras. J Lipid Res. 47:883–891. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kurniansyah N, Goodman MO, Khan AT, Wang
J, Feofanova E, Bis JC, Wiggins KL, Huffman JE, Kelly T, Elfassy T,
et al: Evaluating the use of blood pressure polygenic risk scores
across race/ethnic background groups. Nat Commun. 14:32022023.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Almoguera C, Shibata D, Forrester K,
Martin J, Arnheim N and Perucho M: Most human carcinomas of the
exocrine pancreas contain mutant c-K-ras genes. Cell. 53:549–554.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Court H, Amoyel M, Hackman M, Lee KE, Xu
R, Miller G, Bar-Sagi D, Bach EA, Bergö MO and Philips MR:
Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates
KRAS-driven pancreatic neoplasia via Notch suppression. J Clin
Invest. 123:4681–4694. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lau HY, Ramanujulu PM, Guo D, Yang T,
Wirawan M, Casey PJ, Go ML and Wang M: An improved
isoprenylcysteine carboxylmethyltransferase inhibitor induces
cancer cell death and attenuates tumor growth in vivo. Cancer Biol
Ther. 15:1280–1291. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Glick D, Barth S and Macleod KF:
Autophagy: Cellular and molecular mechanisms. J Pathol. 221:3–12.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yamamoto H, Zhang S and Mizushima N:
Autophagy genes in biology and disease. Nat Rev Genet. 24:382–400.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gómez-Virgilio L, Silva-Lucero MD,
Flores-Morelos DS, Gallardo-Nieto J, Lopez-Toledo G,
Abarca-Fernandez AM, Zacapala-Gómez AE, Luna-Muñoz J, Montiel-Sosa
F, Soto-Rojas LO, et al: Autophagy: A key regulator of homeostasis
and disease: An overview of molecular mechanisms and modulators.
Cells. 11:22622022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nagata S and Golstein P: The fas death
factor. Science. 267:1449–1456. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang J, Liu X, Bhalla K, Kim CN, Ibrado
AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by
Bcl-2: Release of cytochrome c from mitochondria blocked. Science.
275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang J, Zhang A, Wu M and Qin S:
Manipulating mitochondrial electron flow: A novel approach to
enhance tumor immunogenicity. Mol Biomed. 5:102024. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Warburg O, Wind F and Negelein E: The
metabolism of tumors in the body. J Gen Physiol. 8:519–530. 1927.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang X, Xu Z, Wang J, Wu C, Zhang L, Qian
C, Luo Y, Gu Y, Wong WT and Xiang D: A Mitochondria-targeted
biomimetic nanomedicine capable of reversing drug resistance in
colorectal cancer through mitochondrial dysfunction. Adv Sci
(Weinh). 12:e24106302025. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Feng J, Lian Z, Xia X, Lu Y, Hu K, Zhang
Y, Liu Y, Hu L, Yuan K, Sun Z, et al: Targeting metabolic
vulnerability in mitochondria conquers MEK inhibitor resistance in
KRAS-mutant lung cancer. Acta Pharm Sin B. 13:1145–1163. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Manu KA, Chai TF, Teh JT, Zhu WL, Casey PJ
and Wang M: Inhibition of isoprenylcysteine
carboxylmethyltransferase induces Cell-Cycle Arrest and Apoptosis
through p21 and p21-Regulated BNIP3 induction in pancreatic cancer.
Mol Cancer Ther. 16:914–923. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cavalu S, Abdelhamid AM, Saber S, Elmorsy
EA, Hamad RS, Abdel-Reheim MA, Yahya G and Salama MM: Cell cycle
machinery in oncology: A comprehensive review of therapeutic
targets. FASEB J. 38:e237342024. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lau HY, Tang J, Casey PJ and Wang M:
Isoprenylcysteine carboxylmethyltransferase is critical for
malignant transformation and tumor maintenance by all RAS isoforms.
Oncogene. 36:3934–3942. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gewirtz DA, Hilliker ML and Wilson EN:
Promotion of autophagy as a mechanism for radiation sensitization
of breast tumor cells. Radiother Oncol. 92:323–328. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Seyrek K, Wohlfromm F, Espe J and Lavrik
IN: The cross-talk of autophagy and apoptosis in breast carcinoma:
Implications for novel therapies? Biochem J. 479:1581–1608. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang M, Tan W, Zhou J, Leow J, Go M, Lee
HS and Casey PJ: A small molecule inhibitor of isoprenylcysteine
carboxymethyltransferase induces autophagic cell death in PC3
prostate cancer cells. J Biol Chem. 283:18678–18684. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ziemys A, Yokoi K, Kai M, Liu YT, Kojic M,
Simic V, Milosevic M, Holder A and Ferrari M: Progression-dependent
transport heterogeneity of breast cancer liver metastases as a
factor in therapeutic resistance. J Control Release. 291:99–105.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cushman I and Casey PJ: Role of
isoprenylcysteine carboxylmethyltransferase-catalyzed methylation
in Rho function and migration. J Biol Chem. 284:27964–27973. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wen S, Hou Y, Fu L, Xi L, Yang D, Zhao M,
Qin Y, Sun K, Teng Y and Liu M: Cancer-associated fibroblast
(CAF)-derived IL32 promotes breast cancer cell invasion and
metastasis via integrin β3-p38 MAPK signalling. Cancer Lett.
442:320–332. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wei L, Zhou Q, Tian H, Su Y, Fu GH and Sun
T: Integrin β3 promotes cardiomyocyte proliferation and attenuates
hypoxia-induced apoptosis via regulating the PTEN/Akt/mTOR and
ERK1/2 pathways. Int J Biol Sci. 16:644–654. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Do MT, Chai TF, Casey PJ and Wang M:
Isoprenylcysteine carboxylmethyltransferase function is essential
for RAB4A-mediated integrin β3 recycling, cell migration and cancer
metastasis. Oncogene. 36:5757–5767. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells-perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zanconato F, Cordenonsi M and Piccolo S:
YAP/TAZ at the roots of cancer. Cancer Cell. 29:783–803. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Cordenonsi M, Zanconato F, Azzolin L,
Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR,
Poletti A, et al: The Hippo transducer TAZ confers cancer stem
cell-related traits on breast cancer cells. Cell. 147:759–772.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Shao DD, Xue W, Krall EB, Bhutkar A,
Piccioni F, Wang X, Schinzel AC, Sood S, Rosenbluh J, Kim JW, et
al: KRAS and YAP1 converge to regulate EMT and tumor survival.
Cell. 158:171–184. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhang W, Nandakumar N, Shi Y, Manzano M,
Smith A, Graham G, Gupta S, Vietsch EE, Laughlin SZ, Wadhwa M, et
al: Downstream of mutant KRAS, the transcription regulator YAP is
essential for neoplastic progression to pancreatic ductal
adenocarcinoma. Sci Signal. 7:ra422014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Chai TF, Manu KA, Casey PJ and Wang M:
Isoprenylcysteine carboxylmethyltransferase is required for the
impact of mutant KRAS on TAZ protein level and cancer cell
self-renewal. Oncogene. 39:5373–5389. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wang S, Wang W, Zhang S, Yang F, Qiu J,
Guo Q, Zheng J and Chen Z: Isoprenylcysteine carboxyl
methyltransferase promotes the progression of tongue squamous cell
carcinoma via the K-Ras and RhoA signaling pathways. Arch Oral
Biol. 134:1053202022. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Lin L, Cheng X and Yin D: Aberrant DNA
methylation in esophageal squamous cell carcinoma: Biological and
clinical implications. Front Oncol. 10:5498502020. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Klintman J, Appleby N, Stamatopoulos B,
Ridout K, Eyre TA, Robbe P, Pascua LL, Knight SJL, Dreau H, Cabes
M, et al: Genomic and transcriptomic correlates of Richter
transformation in chronic lymphocytic leukemia. Blood.
137:2800–2816. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Richardson C, Moynahan ME and Jasin M:
Homologous recombination between heterologs during repair of a
double-strand break. Suppression of translocations in normal cells.
Ann N Y Acad Sci. 886:183–186. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Iliakis G, Wang Y, Guan J and Wang H: DNA
damage checkpoint control in cells exposed to ionizing radiation.
Oncogene. 22:5834–5847. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI
|
|
72
|
Ajani JA, D'Amico TA, Bentrem DJ, Chao J,
Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, et al:
Gastric cancer, version 2.2022, NCCN clinical practice guidelines
in oncology. J Natl Compr Canc Netw. 20:167–192. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Ma H, Wu F, Bai Y, Wang T, Ma S, Guo L,
Liu G, Leng G, Kong Y and Zhang Y: Licoricidin combats gastric
cancer by targeting the ICMT/Ras pathway in vitro and in vivo.
Front Pharmacol. 13:9728252022. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
75
|
Xu J, Zhu Y, Wang F, Zhou Y, Xia G and Xu
W: ICMT contributes to hepatocellular carcinoma growth, survival,
migration and chemoresistance via multiple oncogenic pathways.
Biochem Biophys Res Commun. 518:584–589. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015.PubMed/NCBI
|
|
77
|
Liu Q, Chen J, Fu B, Dai J, Zhao Y and Lai
L: Isoprenylcysteine carboxylmethyltransferase regulates ovarian
cancer cell response to chemotherapy and Ras activation. Biochem
Biophys Res Commun. 501:556–562. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Bourne HR, Sanders DA and McCormick F: The
GTPase superfamily: A conserved switch for diverse cell functions.
Nature. 348:125–132. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Takashima A and Faller DV: Targeting the
RAS oncogene. Expert Opin Ther Targets. 17:507–531. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Seger R and Krebs EG: The MAPK signaling
cascade. FASEB J. 9:726–735. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wahlstrom AM, Cutts BA, Liu M, Lindskog A,
Karlsson C, Sjogren AK, Andersson KM, Young SG and Bergo MO:
Inactivating Icmt ameliorates K-RAS-induced myeloproliferative
disease. Blood. 112:1357–1365. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Yang WS, Kim HG, Kim E, Han SY, Aziz N, Yi
YS, Kim S, Lee Y, Yoo BC, Han JW, et al: Isoprenylcysteine carboxyl
methyltransferase and its substrate ras are critical players
regulating TLR-Mediated inflammatory responses. Cells. 9:12162020.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Sittewelle M, Kappès V, Zhou C, Lécuyer D
and Monsoro-Burq AH: PFKFB4 interacts with ICMT and activates
RAS/AKT signaling-dependent cell migration in melanoma. Life Sci
Alliance. 5:e2022013772022. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Marín-Ramos NI, Balabasquer M,
Ortega-Nogales FJ, Torrecillas IR, Gil-Ordóñez A, Marcos-Ramiro B,
Aguilar-Garrido P, Cushman I, Romero A, Medrano FJ, et al: A potent
isoprenylcysteine carboxylmethyltransferase (ICMT) inhibitor
improves survival in Ras-Driven acute myeloid leukemia. J Med Chem.
62:6035–6046. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wan W, Xiao W, Pan W, Chen L, Liu Z and Xu
J: Isoprenylcysteine carboxyl methyltransferase is critical for
glioblastoma growth and survival by activating Ras/Raf/Mek/Erk.
Cancer Chemother Pharmacol. 89:401–411. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Colicelli J: Human RAS superfamily
proteins and related GTPases. Sci STKE. 2004:Re132004. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Papaharalambus C, Sajjad W, Syed A, Zhang
C, Bergo MO, Alexander RW and Ahmad M: Tumor necrosis factor alpha
stimulation of Rac1 activity. Role of isoprenylcysteine
carboxylmethyltransferase. J Biol Chem. 280:18790–18796. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Cushman I and Casey PJ: RHO methylation
matters: A role for isoprenylcysteine carboxylmethyltransferase in
cell migration and adhesion. Cell Adh Migr. 5:11–15. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Schwartz SL, Cao C, Pylypenko O, Rak A and
Wandinger-Ness A: Rab GTPases at a glance. J Cell Sci.
120:3905–3910. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Court H, Ahearn IM, Amoyel M, Bach EA and
Philips MR: Regulation of NOTCH signaling by RAB7 and RAB8 requires
carboxyl methylation by ICMT. J Cell Biol. 216:4165–4182. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Roberts M, Barry S, Woods A, van der
Sluijs P and Norman J: PDGF-regulated rab4-dependent recycling of
alphavbeta3 integrin from early endosomes is necessary for cell
adhesion and spreading. Curr Biol. 11:1392–1402. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
White DP, Caswell PT and Norman JC: Alpha
v beta3 and alpha5beta1 integrin recycling pathways dictate
downstream Rho kinase signaling to regulate persistent cell
migration. J Cell Biol. 177:515–525. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Yang WS, Kim HG, Lee Y, Yoon K, Kim S, Kim
JH and Cho JY: Isoprenylcysteine carboxyl methyltransferase
inhibitors exerts anti-inflammatory activity. Biochem Pharmacol.
182:1142192020. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Judd WR, Slattum PM, Hoang KC, Bhoite L,
Valppu L, Alberts G, Brown B, Roth B, Ostanin K, Huang L, et al:
Discovery and SAR of methylated tetrahydropyranyl derivatives as
inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT).
J Med Chem. 54:5031–5047. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Chen X, Yao H, Kashif M, Revêchon G,
Eriksson M, Hu J, Wang T, Liu Y, Tüksammel E, Strömblad S, et al: A
small-molecule ICMT inhibitor delays senescence of
Hutchinson-Gilford progeria syndrome cells. Elife. 10:e632842021.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Marcos-Ramiro B, Gil-Ordóñez A,
Marín-Ramos NI, Ortega-Nogales FJ, Balabasquer M, Gonzalo P,
Khiar-Fernández N, Rolas L, Barkaway A, Nourshargh S, et al:
Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for
Hutchinson-Gilford Progeria Syndrome. ACS Cent Sci. 7:1300–1310.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Jayaram B, Syed I, Singh A, Subasinghe W,
Kyathanahalli CN and Kowluru A: Isoprenylcysteine carboxyl
methyltransferase facilitates glucose-induced Rac1 activation, ROS
generation and insulin secretion in INS 832/13 β-cells. Islets.
3:48–57. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Koera K, Nakamura K, Nakao K, Miyoshi J,
Toyoshima K, Hatta T, Otani H, Aiba A and Katsuki M: K-ras is
essential for the development of the mouse embryo. Oncogene.
15:1151–1159. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Nakamura K, Ichise H, Nakao K, Hatta T,
Otani H, Sakagami H, Kondo H and Katsuki M: Partial functional
overlap of the three ras genes in mouse embryonic development.
Oncogene. 27:2961–2968. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Fuentes-Mateos R, Jimeno D, Gómez C,
Calzada N, Fernández-Medarde A and Santos E: Concomitant deletion
of HRAS and NRAS leads to pulmonary immaturity, respiratory failure
and neonatal death in mice. Cell Death Dis. 10:8382019. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Cui XS, Li XY and Kim NH: Cdc42 is
implicated in polarity during meiotic resumption and blastocyst
formation in the mouse. Mol Reprod Dev. 74:785–794. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Sugihara K, Nakatsuji N, Nakamura K, Nakao
K, Hashimoto R, Otani H, Sakagami H, Kondo H, Nozawa S, Aiba A, et
al: Rac1 is required for the formation of three germ layers during
gastrulation. Oncogene. 17:3427–3433. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
He X, Liu J, Qi Y, Brakebusch C,
Chrostek-Grashoff A, Edgar D, Yurchenco PD, Corbett SA, Lowry SF,
Graham AM, et al: Rac1 is essential for basement membrane-dependent
epiblast survival. Mol Cell Biol. 30:3569–3581. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Dickinson ME, Flenniken AM, Ji X, Teboul
L, Wong MD, White JK, Meehan TF, Weninger WJ, Westerberg H, Adissu
H, et al: High-throughput discovery of novel developmental
phenotypes. Nature. 537:508–514. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Wu Y, Yang D and Chen GY: Targeted
disruption of Rab1a causes early embryonic lethality. Int J Mol
Med. 49:462022. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Dekker FJ, Rocks O, Vartak N, Menninger S,
Hedberg C, Balamurugan R, Wetzel S, Renner S, Gerauer M,
Schölermann B, et al: Small-molecule inhibition of APT1 affects Ras
localization and signaling. Nat Chem Biol. 6:449–456. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Ibrahim MX, Sayin VI, Akula M, Liu M, Fong
LG, Young SG and Bergo MO: Targeting isoprenylcysteine methylation
ameliorates disease in a mouse model of progeria. Science.
340:1330–1333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Bergo MO, Lieu HD, Gavino BJ, Ambroziak P,
Otto JC, Casey PJ, Walker QM and Young SG: On the physiological
importance of endoproteolysis of CAAX proteins: Heart-specific RCE1
knockout mice develop a lethal cardiomyopathy. J Biol Chem.
279:4729–4736. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Wang MT, Holderfield M, Galeas J,
Delrosario R, To MD, Balmain A and McCormick F: K-Ras promotes
tumorigenicity through suppression of Non-canonical wnt signaling.
Cell. 163:1237–1251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Farmer H, McCabe N, Lord CJ, Tutt AN,
Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I,
Knights C, et al: Targeting the DNA repair defect in BRCA mutant
cells as a therapeutic strategy. Nature. 434:917–921. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Sinnett-Smith J, Anwar T, Reed EF, Teper
Y, Eibl G and Rozengurt E: Opposite effects of src family kinases
on YAP and ERK activation in pancreatic cancer cells: Implications
for targeted therapy. Mol Cancer Ther. 21:1652–1662. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Wang H, Tao Y, Han J, Shen J, Mu H, Wang
Z, Wang J, Jin X, Zhang Q, Yang Y, et al: Disrupting YAP1-mediated
glutamine metabolism induces synthetic lethality alongside ODC1
inhibition in osteosarcoma. Cell Oncol (Dordr). 47:1845–1861. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Ren F, Yi Y, Lu T, Liu X, Cui G, Huang S,
Parada LF and Chen J: Synthetic lethality through Gsk3β inhibition
in glioma stem cells via the WNT-WWC1-YAP axis. Oncogene.
44:2427–2439. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Vasan N, Baselga J and Hyman DM: A view on
drug resistance in cancer. Nature. 575:299–309. 2019. View Article : Google Scholar : PubMed/NCBI
|
